Original language | English |
---|---|
Pages (from-to) | iii9 |
Journal | Annals of Oncology |
Volume | 29 |
DOIs | |
Publication status | Published - 2018 |
CC-122, a novel cereblon-modulating agent, in combination with obinutuzumab (GA101) in patients with relapsed and refractory (R/R) B-cell non-hodgkin lymphoma (NHL)
J. M. Michot, R. Bouabdallah, J. K. Doorduijn, U. Vitolo, M. J. Kersten, A. Chiappella, P. L. Zinzani, M. Pourdehnad, Z. Nikolova, V. Ribrag
Research output: Contribution to journal › Article › Academic › peer-review